TIMENTIN - 0029-6571-26 - (ticarcillin disodium and clavulanate potassium)

Alphabetical Index


Drug Information of TIMENTIN

Product NDC: 0029-6571
Proprietary Name: TIMENTIN
Non Proprietary Name: ticarcillin disodium and clavulanate potassium
Active Ingredient(s): 1; 30    mg/mL; mg/mL & nbsp;   ticarcillin disodium and clavulanate potassium
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of TIMENTIN

Product NDC: 0029-6571
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA050590
Marketing Category: NDA
Start Marketing Date: 19901022

Package Information of TIMENTIN

Package NDC: 0029-6571-26
Package Description: 10 VIAL in 1 TRAY (0029-6571-26) > 50 mL in 1 VIAL

NDC Information of TIMENTIN

NDC Code 0029-6571-26
Proprietary Name TIMENTIN
Package Description 10 VIAL in 1 TRAY (0029-6571-26) > 50 mL in 1 VIAL
Product NDC 0029-6571
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ticarcillin disodium and clavulanate potassium
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19901022
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM
Strength Number 1; 30
Strength Unit mg/mL; mg/mL
Pharmaceutical Classes beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA],Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient]

Complete Information of TIMENTIN


General Information